Effect of Fish Oil and Vitamin C on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma
Comparative and Additive Effects of Fish Oil and Ascorbic Acid Supplementation on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma
1 other identifier
interventional
14
1 country
1
Brief Summary
Combining fish oil and vitamin C supplementation will provide a greater anti-inflammatory effect against developing exercise-induced bronchoconstriction (EIB) than either nutritional supplement alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1 asthma
Started Mar 2010
Typical duration for phase_1 asthma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 26, 2010
CompletedFirst Posted
Study publicly available on registry
January 27, 2010
CompletedStudy Start
First participant enrolled
March 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedJanuary 31, 2011
January 1, 2011
9 months
January 26, 2010
January 28, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pulmonary Function
8 weeks
Secondary Outcomes (1)
Exhaled nitric oxide to measure airway inflammation
8 weeks
Study Arms (3)
Active Fish Oil + Vitamin C Placebo
EXPERIMENTALFifteen subjects will take 10 active fish oil capsules per day and 2 vitamin C placebo capsules per day for 3 weeks.
Fish Oil Placebo + Active Vitamin C
EXPERIMENTALFifteen subjects will take 10 fish oil placebo capsules per day and 2 active vitamin C capsules per day for 3 weeks.
Active Fish Oil + Active Vitamin C
EXPERIMENTALFollowing a 2-week washout period, all subjects from the other two arms (n=30) will take 10 active fish oil capsules per day and 2 active vitamin C capsules per day for 3 weeks.
Interventions
10 fish oil (3.2g EPA + 2.0g DHA) capsules per day for 3 weeks
2 pharmaceutical grade ascorbic acid (1500mg) capsules per day for 3 weeks
10 placebo fish oil (soy bean oil) capsules per day for 3 weeks
2 placebo ascorbic acid (sucrose) capsules per day for 3 weeks
Eligibility Criteria
You may qualify if:
- Diagnosis of asthma, based on medication use as well as history and symptoms as outlined in the NHLBI Guidelines for the Diagnosis and Management of Asthma
- Diagnosis of EIB, based on ≥10% fall in post-challenge FEV1, a measure of lung function, after dry air eucapnic voluntary hyperventilation (EVH), a simulated exercise challenge
- Not currently taking asthma maintenance medication or physician approval to discontinue current asthma medication for the duration of the study
- Not currently taking any fish oil or ascorbic acid supplements above the level recommended for adequate intake (if currently taking supplements, can participate if the subject stops taking the supplements for 2 weeks before starting the study and throughout the study)
- Agree to limit fish consumption to 1 fish meal per week throughout the study
- Agree to avoid vitamin C-rich foods throughout the study
You may not qualify if:
- Resting FEV1 (the amount of air blown out in the first second of a forced exhalation) \<60% of predicted when off medication
- Pregnancy
- History of cardiovascular disease, including hyperlipidemia (high cholesterol) and hypertension (high blood pressure)
- History of bleeding disorders or delayed clotting time
- History of diabetes
- History of seizures
- Allergy to fish oil or ascorbic acid (vitamin C)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Indiana University
Bloomington, Indiana, 47405, United States
Related Publications (3)
Mickleborough TD, Murray RL, Ionescu AA, Lindley MR. Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med. 2003 Nov 15;168(10):1181-9. doi: 10.1164/rccm.200303-373OC. Epub 2003 Aug 6.
PMID: 12904324BACKGROUNDMickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest. 2006 Jan;129(1):39-49. doi: 10.1378/chest.129.1.39.
PMID: 16424411BACKGROUNDTecklenburg SL, Mickleborough TD, Fly AD, Bai Y, Stager JM. Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma. Respir Med. 2007 Aug;101(8):1770-8. doi: 10.1016/j.rmed.2007.02.014. Epub 2007 Apr 5.
PMID: 17412579BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Timothy D Mickleborough, PhD
Indiana University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 26, 2010
First Posted
January 27, 2010
Study Start
March 1, 2010
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
January 31, 2011
Record last verified: 2011-01